Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS)
CNY 29.1
(-2.68%)
CNY 29.1
(-2.68%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 346.77 Million CNY | -19.71% |
| 2022 | 431.91 Million CNY | -8.21% |
| 2021 | 470.56 Million CNY | 23.32% |
| 2020 | 381.57 Million CNY | 389.43% |
| 2019 | 77.96 Million CNY | 3.22% |
| 2018 | 75.53 Million CNY | 52.96% |
| 2017 | 49.38 Million CNY | 9.25% |
| 2016 | 45.2 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 384.97 Million CNY | 11.01% |
| 2024 Q2 | 426.26 Million CNY | 10.73% |
| 2024 Q3 | 427.26 Million CNY | 0.23% |
| 2023 Q1 | 372.53 Million CNY | -13.75% |
| 2023 FY | 346.77 Million CNY | -19.71% |
| 2023 Q4 | 346.77 Million CNY | -19.27% |
| 2023 Q3 | 429.53 Million CNY | 3.67% |
| 2023 Q2 | 414.32 Million CNY | 11.22% |
| 2022 Q2 | 1.29 Billion CNY | 63.86% |
| 2022 Q1 | 788.25 Million CNY | 67.51% |
| 2022 FY | 431.91 Million CNY | -8.21% |
| 2022 Q4 | 431.91 Million CNY | -64.17% |
| 2022 Q3 | 1.2 Billion CNY | -6.68% |
| 2021 Q1 | 619.94 Million CNY | 62.47% |
| 2021 FY | 470.56 Million CNY | 23.32% |
| 2021 Q2 | 553.75 Million CNY | -10.68% |
| 2021 Q3 | 474.2 Million CNY | -14.37% |
| 2021 Q4 | 470.56 Million CNY | -0.77% |
| 2020 Q4 | 381.57 Million CNY | 55.27% |
| 2020 FY | 381.57 Million CNY | 389.43% |
| 2020 Q3 | 245.74 Million CNY | 7.79% |
| 2020 Q2 | 227.98 Million CNY | 113.59% |
| 2020 Q1 | 106.74 Million CNY | 36.91% |
| 2019 Q3 | 72.36 Million CNY | 1.4% |
| 2019 Q4 | 77.96 Million CNY | 7.73% |
| 2019 Q2 | 71.37 Million CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 FY | 77.96 Million CNY | 3.22% |
| 2018 FY | 75.53 Million CNY | 52.96% |
| 2018 Q4 | 75.53 Million CNY | 0.0% |
| 2017 FY | 49.38 Million CNY | 9.25% |
| 2016 FY | 45.2 Million CNY | 0.0% |